EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors

Son Pham, Boyang Zhao, Neetu Neetu, Banumathi Sankaran, Ketki Patil, Sasirekha Ramani iD, Yongcheng Song, Mary K Estes iD, Timothy Palzkill, B V Venkataram Prasad iD

Journal of Virology · 2025

DOI: 10.1128/jvi.01757-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Son Pham und 9 weiteren Autor:innen. Beteiligte Einrichtung: Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Norovirus, Protease Inhibitors, Antiviral Agents, Viral Proteases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Welch Foundation (The Welch Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human norovirus (HuNoV) is a leading cause of gastroenteritis worldwide and is associated with significant morbidity, mortality, and economic impact. There are currently no licensed antiviral drugs for the treatment of HuNoV-associated gastroenteritis. The HuNoV protease plays a critical role in the initiation of virus replication by cleaving the polyprotein. Thus, it is an ideal target for developing antiviral small-molecule inhibitors. While rupintrivir, a potent small-molecule inhibitor of several picornavirus proteases, effectively inhibits GI.1 protease, it is an order of magnitude less effective against GII protease. Other GI.1 protease inhibitors also tend to be less effective against GII proteases. To understand the structural basis for the potency difference, we determined the crystal structures of proteases of GI.1, pandemic GII.4 (Houston and Sydney), and GII.3 in complex with rupintrivir. These structures show that the open substrate pocket in GI protease binds rupintrivir without requiring significant conformational changes, whereas, in GII proteases, the closed pocket flexibly extends, reorienting arginine-112 in the BII-CII loop to accommodate rupintrivir. Structures of R112A protease mutants with rupintrivir, coupled with enzymatic and inhibition studies, suggest R112 is involved in displacing both substrate and ligands from the active site, implying a role in the release of cleaved products during polyprotein processing. Thus, the primary determinant for differential inhibitor potency between the GI and GII proteases is the increased flexibility in the BII-CII loop of the GII proteases caused by the H-G mutation in this loop. Therefore, the inherent flexibility of the BII-CII loop in GII proteases is a critical factor to consider when developing broad-spectrum inhibitors for HuNoV proteases. IMPORTANCE Human noroviruses are a significant cause of sporadic and epidemic gastroenteritis worldwide. There are no vaccines or antiviral drugs currently available to treat infections. Our work elucidates the structural differences between GI.1 and GII proteases in response to inhibitor binding and will inform the future development of broad-spectrum norovirus protease inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NorovirusProtease InhibitorsAntiviral AgentsViral ProteasesCaliciviridae InfectionsGastroenteritisCrystallographyMolecular ConformationCatalytic DomainHumansIsoxazolesPhenylalaninePyrrolidinonesValine

Stichwörter der Autor:innen

GII.4X-ray crystallographyantiviralconformational flexibilityenzyme kineticsinhibitornorovirusprotease

Substanzen

Protease InhibitorsAntiviral AgentsViral ProteasesrupintrivirIsoxazolesPhenylalaninePyrrolidinonesValine

Autor:innen und Institutionen

  • Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Berkeley Center for Structural Biology, Molecular Biophysics, and Integrated Bioimaging, Lawrence Berkeley Laboratory, Berkeley, California, USA.
  • Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Sasirekha Ramani, Mary K Estes, B V Venkataram Prasad

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Welch Foundation (The Welch Foundation)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Pham, S., Zhao, B., Neetu, N., Sankaran, B., Patil, K., Ramani, S., Song, Y., Estes, M. K., Palzkill, T., & Prasad, B. V. V. (2025). Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. Journal of Virology. https://doi.org/10.1128/jvi.01757-24

Vancouver

Pham S, Zhao B, Neetu N, Sankaran B, Patil K, Ramani S, et al. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. Journal of Virology. 2025. doi:10.1128/jvi.01757-24

BibTeX
@article{Pham2025,
  author = {Pham, Son and Zhao, Boyang and Neetu, Neetu and Sankaran, Banumathi and Patil, Ketki and Ramani, Sasirekha and Song, Yongcheng and Estes, Mary K and Palzkill, Timothy and Prasad, B V Venkataram},
  title = {Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.01757-24}
}
Kostenlos starten →